Cooperative Agreement NU62PS924872
- Federal Cooperative Agreement Summary Award Overview The City of New York Department of Health and Mental Hygiene received a $1.31 million Cooperative Agreement from the Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) Surveillance program (CFDA 93.944). The award, dated September 30, 2025, with a completion date of September 29, 2030, supports the Medical Monitoring Project...
- Federal Cooperative Agreement Summary The New Jersey Department of Health (NJDOH) received a Cooperative Agreement award of $1,796,440 from the National Center for HIV/AIDS, Centers for Disease Control and Prevention (CDC), under the HIV Prevention and Surveillance Activities-Health Department Based program (CFDA 93.940). The award was obligated on September 30, 2025, with an ultimate completion date of September 29, 2030. Through this five-year cooperative agreement, NJDOH will implement the...
- Federal Cooperative Agreement Summary The California Department of Public Health received a $1.91 million Cooperative Agreement from the Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) Surveillance program (CFDA 93.944). Awarded on September 30, 2025, with a completion date of September 29, 2030, this five-year award supports the Medical Monitoring Project (MMP), a comprehensive...
- Federal Cooperative Agreement Award Summary The Centers for Disease Control and Prevention (CDC) National Center for HIV/AIDS awarded a Cooperative Agreement (CFDA 93.944) to the Indiana Department of Health totaling $1,029,252 with an award date of September 30, 2025, and a completion date of September 29, 2030. This funding supports the Medical Monitoring Project (MMP), which is part of the broader Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS)...
- Federal Cooperative Agreement Award Summary The Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, awarded a $845,909 Cooperative Agreement to the State of Georgia Department of Public Health (GDPH) effective September 30, 2025, through September 29, 2030. This award supports the Georgia Medical Monitoring Project (MMP) under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) Surveillance program (CFDA 93.944). The project delivers...
- Grant Award Summary The San Francisco Department of Public Health (SFDPH) received a $643,882 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention and Surveillance Activities-Health Department Based program (CFDA 93.940), effective September 30, 2025, through September 29, 2030. This award supports the Medical Monitoring Project (MMP), a key surveillance initiative that collects and analyzes behavioral and clinical data on people with HIV (PWH)...
- Summary: Medical Monitoring Project (PS25-0008) The North Carolina Department of Health and Human Services (NC DHHS) received a $683,360 cooperative agreement from the Centers for Disease Control and Prevention (CDC) under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) Surveillance program (CFDA 93.944), awarded September 30, 2025, with a completion date of September 29, 2030. The Medical Monitoring Project (MMP) delivers comprehensive HIV surveillance...
- Federal Cooperative Agreement Award Summary The Commonwealth of Virginia State Board of Health, Office of Epidemiology, received a $664,068 cooperative agreement from the Centers for Disease Control and Prevention (CDC) under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) Surveillance program (CFDA 93.944). The award, effective September 30, 2025 through September 29, 2030, funds the Medical Monitoring Project (MMP), which conducts comprehensive HIV surveillance...
- Federal Cooperative Agreement Summary: PS25-0008 Medical Monitoring Project The Illinois Department of Public Health received a Cooperative Agreement award of $2,792,523 from the National Center for HIV/AIDS (part of the Centers for Disease Control and Prevention) under the HIV Prevention and Surveillance Activities—Health Department Based program (CFDA 93.940). This award, effective September 30, 2025 through September 29, 2029, supports the establishment and maintenance of comprehensive HIV...
- Federal Cooperative Agreement Summary The Executive Office of the Governor of Delaware, Division of Public Health, received a $360,444 cooperative agreement from the Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) Surveillance program (CFDA 93.944). The award was issued September 30, 2025, with a performance period through September 29, 2030. Under this cooperative agreement,...
Health Research, Inc., operating as Health Research At The Aids Institute, received a $592,926 Cooperative Agreement from the National Center for HIV/AIDS (Centers for Disease Control and Prevention) under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) Surveillance program (CFDA 93.944) on September 30, 2025. The five-year performance period extends through September 29, 2030. The Medical Monitoring Project (MMP) delivers comprehensive HIV surveillance and monitoring activities focused on tracking HIV incidence and prevalence, collecting behavioral and clinical data, and conducting medical record reviews to support national and local HIV prevention and treatment strategies. The project serves the New York City area and contributes to broader epidemiological understanding of HIV transmission patterns and identification of high-risk populations. As a established provider of HIV/AIDS care and prevention services across New York State, Health Research, Inc. leverages this funding to strengthen surveillance infrastructure and data management systems that inform public health interventions. The MMP award supports the organization's capacity to conduct targeted behavioral interviews, facilitate testing initiatives, and generate surveillance data that enable public health officials to identify emerging trends and develop evidence-based prevention and care strategies for vulnerable populations living with or at risk for HIV infection.Federal Cooperative Agreement Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $592.9k | 1/21/26 | ||
| Not listed | ($593k) | 12/10/25 | ||
| Not listed | ($593k) | 12/10/25 | ||
| Not listed | $592.9k | 9/29/25 | ||
| Not listed | $592.9k | 9/29/25 |